评估Illumina(ILMN)在近期股价疲软与长期回报波动后的估值 - simplywall.st
Assessing Illumina (ILMN) Valuation After Recent Share Price Weakness And Mixed Long Term Returns - simplywall.st
生物技术与制药领域的最新动态
Assessing Illumina (ILMN) Valuation After Recent Share Price Weakness And Mixed Long Term Returns - simplywall.st
Illumina (ILMN) One Off Gain Shapes Profitability Narrative After FY 2025 Earnings - simplywall.st
Illumina Earnings Call Highlights Clinical Growth Momentum - TipRanks
Key facts: Illumina Q4 2025 revenue rises to $1.16B; 2026 growth forecasted - TradingView
Illumina Enters Oversold Territory (ILMN) - Nasdaq
Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript - Insider Monkey
Illumina bets on healthcare after Trump administration's NIH funding disruptions
Illumina bets on healthcare customers after NIH funding disruptions - Endpoints News
PBSA Market Is Booming Worldwide With Agilent Technologies • Bio-Rad Laboratories • PerkinElmer • Illumina - openPR.com
Illumina Q4 Earnings Call Highlights - Yahoo Finance
Illumina: Q4 Earnings Snapshot - kens5.com
Illumina shares tumble as flat revenue disappoints investors By Investing.com - Investing.com
Illumina Inc. Q4 Profit Advances - Nasdaq
Illumina (NASDAQ:ILMN) Reports Bullish Q4 CY2025 - TradingView
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 - PR Newswire
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 - Yahoo Finance
Illumina earnings loom as investors seek clarity on 2026 outlook By Investing.com - Investing.com
Illumina Wildlife Genomics Deal Highlights New Conservation And Valuation Story - simplywall.st
Insights Into Illumina (ILMN) Q4: Wall Street Projections for Key Metrics - Yahoo! Finance Canada
Mediolanum International Funds Ltd Makes New $914,000 Investment in Illumina, Inc. $ILMN - MarketBeat